Anti-M Alloimmunization following Term Stillbirth: A Case Report and Review of the Literature

Abstract

Alloimmunization due to anti-M antibodies are rare since they present as naturally occurring immunoglobulin M antibodies, which do not cross the placenta. Very rarely, these may convert to immunoglobulin G antibodies and cause hemolytic disease of the fetus and newborn. We present the case of a fifth gravida, with previous two miscarriages and an unexplained stillbirth, booked with us for the 8 weeks. At booking, she was found to have anti-M antibodies with titers of 1:2, which was stable throughout pregnancy. At 35 weeks, there was evidence of severe fetal anemia and features of hydrops on the ultrasound scan, requiring delivery. Neonatal direct Coombs test was positive. Baby had a hemoglobin of 8.8 mg/dL and a reticulocyte count of 5.5% at birth, requiring two units of blood transfusion. He also required 6 days of intensive phototherapy. Alloimmunization due to anti-M antibodies should be suspected in women with previous bad obstetric history. The maternal antibody titers may not be a true reflection of the severity of fetal affection, and hence not reliable for monitoring in pregnancy

Keywords

alloimmunization - anti-M antibodies - fetal hydrops - hemolytic disease of fetus and newborn - stillbirth

Financial Disclosure

None.

Informed Consent

Taken.

Animal Research Statement

Not applicable.

Publikationsverlauf

Artikel online veröffentlicht:
12. Mai 2023

• References

• 1 Moise Jr KJ, Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol 2012; 120 (05) 1132-1139
• 2 Fung MK, Grossman BJ, Hillyer CD, Westhof CM. Core Principles in Cellular Therapy, 18th ed. Bethesda, MD: AABB; 2014. :viii, 96
• 3 Bajpayee A, Dubey A, Sonker A, Chaudhary RK. A case of severe foetal anaemia due to anti-M isoimmunisation salvaged by intrauterine transfusions. Blood Transfus 2014; 12 (Suppl 1, Suppl 1): s302-s304
• 4 Karim F, Moiz B, Kamran N. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women. Transfus Apheresis Sci 2015; 52 (01) 99-102
• 5 Stetson B, Scrape S, Markham KB. Anti-M Alloimmunization. AJP Rep 2017; 7 (04) e205-e210
• 6 Li S, He Z, Luo Y. et al. Distribution of maternal red cell antibodies and the risk of severe alloimmune haemolytic disease of the foetus in a Chinese population: a cohort study on prenatal management. BMC Pregnancy Childbirth 2020; 20 (01) 539
• 7 Yasuda H, Ohto H, Nollet KE. et al. Hemolytic disease of the fetus and newborn with late-onset anemia due to anti-M: a case report and review of the Japanese literature. Transfus Med Rev 2014; 28 (01) 1-6
• 8 Gao XY, Huang H, Li LD. [Hemolytic disease of neonates due to anti-M: report of one case and review of reports of 21 cases]. . [article in Chinese] Zhonghua Er Ke Za Zhi 2009; 47 (09) 648-652
• 9 Li S, Mo C, Huang L. et al. Hemolytic disease of the fetus and newborn due to alloanti-M: three Chinese case reports and a review of the literature. Transfusion 2019; 59 (01) 385-395
• 10 Late Intrauterine Fetal Death and Stillbirth (Green-top Guideline No. 55). Accessed March 21, 2023 at: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/late-intrauterine-fetal-death-and-stillbirth-green-top-guideline-no-55/
• 11 The Management of Women with Red Cell Antibodies during Pregnancy (Green-top Guideline No. 65). Accessed March 21, 2023 at: https://www.rcog.org.uk/guidance/browse-all-guidance/green-top-guidelines/the-management-of-women-with-red-cell-antibodies-during-pregnancy-green-top-guideline-no-65/